What are the major opportunities in the Saxenda market? What are the strategies for the Saxenda market?

For detailed insights on the major opportunities and strategies in the Saxenda market, Read More

How does the Saxenda market relate to the overall economy and other similar markets?

For detailed insights on Saxenda's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Saxenda industry?

For detailed insights on the mergers and acquisitions in the Saxenda industry, Read More

What are the key dynamics influencing the Saxenda market growth? SWOT analysis of the Saxenda market.

For detailed insights on the key dynamics influencing the Saxenda market growth and SWOT analysis of the Saxenda industry, Read More

Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Saxenda Global Market Report 2025

Name: Saxenda Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Indication (Obesity Management (Body Mass Index (BMI) of =30 kg/m²), Overweight Management (BMI of =27 kg/m² to <30 kg/m² with weight-related comorbidities)), By Dosage Form (Injection, Pre-filled pens), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals And Clinics, Homecare Settings)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Saxenda Market?

Saxenda is a prescription medication containing liraglutide, designed to aid in weight management for adults with obesity or overweight conditions. It works by mimicking a hormone in the body that regulates appetite, helping individuals reduce caloric intake and achieve sustained weight loss when combined with a reduced-calorie diet and increased physical activity.

The main indications of saxenda include obesity management (body mass index (BMI) of =30 kg/m²) and overweight management (BMI of =27 kg/m² to <30 kg/m² with weight-related comorbidities). Obesity is characterized by a body mass index (BMI) of 30 kg/m² or higher, indicating excessive body fat accumulation. This condition significantly increases the risk of developing chronic health issues such as type 2 diabetes, hypertension, and cardiovascular diseases. The several dosage forms include injections and pre-filled pens and are distributed through various channels such as hospital pharmacies, retail pharmacies, and online pharmacies. The various end users include Hospitals and clinics and homecare settings.

Saxenda Market Size and growth rate 2025 to 2029: Graph

What Is The Saxenda Market Size 2025 And Growth Rate?

The saxenda market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increased prevalence of obesity, growth in sedentary lifestyles, rise in awareness of obesity-related health risks, increased adoption of weight management treatments, and expansion of healthcare access.

What Is The Saxenda Market Growth Forecast?

The saxenda market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growing personalized medicine, expanding healthcare infrastructure, rising demand for non-surgical weight loss solutions, and increasing use of digital health tools. Major trends in the forecast period include the emergence of combination therapies for weight loss, increasing availability of prescription weight loss medications, rising adoption of digital health and fitness apps, integration of weight management solutions into primary care, and greater focus on sustainable lifestyle changes.

Book your 30 minutes free consultation with our research experts

How Is The Saxenda Market Segmented?

The saxenda market covered in this report is segmented –

1) By Indication: Obesity Management (Body Mass Index (BMI) of =30 kg/m²); Overweight Management (BMI of =27 kg/m² to <30 kg/m² with weight-related comorbidities)

2) By Dosage Form: Injection; Pre-filled pens

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

4) By End User: Hospitals And Clinics; Homecare Settings

What Is Driving The Saxenda Market? Rising Obesity Prevalence Drives Demand For Weight-Loss Treatments

The rising prevalence of obesity is expected to propel the growth of the saxenda market going forward. Obesity is a health condition marked by an excess of body fat, which raises the risk of various health issues like diabetes, heart disease, and certain cancers. The rising prevalence of obesity can be attributed to several factors, including unhealthy diets, sedentary lifestyles, urbanization, genetic factors, and hormonal imbalances. Saxenda helps combat obesity by regulating appetite through its active ingredient, liraglutide, which mimics the natural hormone GLP-1 to promote feelings of fullness, reduce caloric intake, and support sustainable weight loss when combined with a healthy diet and regular physical activity. For instance, in May 2024, according to a report published by the Office for Health Improvement and Disparities (OHID), a UK-based government agency, an estimated 64.0% of adults aged 18 years and over in England were overweight or living with obesity in 2022 to 2023, with 26.2% living with obesity, similar to the figures from 2021 to 2022 (63.8% and 25.9%, respectively). Therefore, the rising prevalence of obesity is driving the growth of the saxenda market.

What Is Driving The Saxenda Market? Rising Diabetes Prevalence Boosts Demand For Saxenda's Weight Management Solutions

The rising prevalence of diabetes is expected to propel the growth of the saxenda market going forward. Diabetes is a long-term condition that impacts the body's ability to regulate blood sugar (glucose) levels. The rising prevalence of diabetes is mainly due to factors such as unhealthy diets, sedentary lifestyles, obesity, aging populations, and genetic predisposition. Saxenda helps manage diabetes by leveraging its active ingredient, liraglutide, to enhance insulin sensitivity, regulate blood sugar levels, and slow gastric emptying, providing comprehensive support for glycemic control alongside its weight management benefits. For instance, in February 2023, according to a report published by Diabetes Canada, a Canada-based national charitable organization, nearly 30% of Ontario's population, or 2.4 million people, lived with diabetes or prediabetes in 2023, with a projected 25% increase in prevalence over the next decade, raising treatment costs from $1.7 billion to $2.1 billion annually by 2033. Therefore, the rising prevalence of diabetes is driving the growth of the saxenda market.

Who Are The Major Players In The Global Saxenda Market?

Major companies operating in the saxenda market are Novo Nordisk

What Are The Key Trends Of The Global Saxenda Market? Innovative Generic Products Expand Affordable Alternatives For Weight Management

A key trend in the saxenda market is developing innovative products, such as generic products for weight management, to expand the availability of an affordable, approved alternative for weight management. A generic product for weight management refers to a medication that is chemically identical to a brand-name weight loss drug, providing the same therapeutic effects but marketed under its chemical name or a different brand name, typically at a lower cost. For instance, in April 2024, Biocon Limited, an India-based biopharmaceutical company, announced the approval of its generic formulation, Liraglutide (gSaxenda), by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK. This product, available as a 6 mg/ml solution in a pre-filled pen, is designed to aid in weight management when combined with a reduced-calorie diet and increased physical activity. The approval highlights the significance of cost-effective alternatives in addressing obesity, further strengthening Biocon's portfolio of vertically integrated, complex drug products.

Need data on a specific region in this market?

Request Regional Data

Regional Analysis For The Global Saxenda Market

North America was the largest region in the saxenda market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the saxenda market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the saxenda market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Saxenda Market?

The saxenda market consists of sales of products such as prefilled pens of 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg, and 3 mg. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Saxenda Industry?

The saxenda market research report is one of a series of new reports from The Business Research Company that provides saxenda market statistics, including saxenda industry global market size, regional shares, competitors with saxenda market share, detailed saxenda market segments, market trends and opportunities, and any further data you may need to thrive in the saxenda industry. This saxenda market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Author : Abhilash Pyata

Saxenda Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included ?
Revenue Forecast In 2034	Included ?
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The saxenda market covered in this report is segmented – 1) By Indication: Obesity Management (Body Mass Index (BMI) of =30 kg/m²); Overweight Management (BMI of =27 kg/m² to <30 kg/m² with weight-related comorbidities) 2) By Dosage Form: Injection; Pre-filled pens 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies 4) By End User: Hospitals And Clinics; Homecare Settings
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Novo Nordisk
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Saxenda Market Characteristics

3. Saxenda Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Saxenda Market Trends And Strategies

5. Saxenda Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Saxenda Growth Analysis And Strategic Analysis Framework

6.1. Global Saxenda PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Saxenda Market Growth Rate Analysis

6.4. Global Saxenda Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Saxenda Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Saxenda Total Addressable Market (TAM)

7. Global Saxenda Pricing Analysis & Forecasts

8. Saxenda Market Segmentation

8.1. Global Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Obesity Management (Body Mass Index (BMI) of =30 kg/m²)

Overweight Management (BMI of =27 kg/m² to <30 kg/m² with weight-related comorbidities)

8.2. Global Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Injection

Pre-filled pens

8.3. Global Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

8.4. Global Saxenda Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospitals And Clinics

Homecare Settings

9. Global Saxenda Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Saxenda Market Regional And Country Analysis

10.1. Global Saxenda Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Saxenda Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Saxenda Market

11.1. Asia-Pacific Saxenda Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Saxenda Market

12.1. China Saxenda Market Overview

12.2. China Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Saxenda Market

13.1. India Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Saxenda Market

14.1. Japan Saxenda Market Overview

14.2. Japan Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Saxenda Market

15.1. Australia Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Saxenda Market

16.1. South Korea Saxenda Market Overview

16.2. South Korea Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Saxenda Market

17.1. Western Europe Saxenda Market Overview

17.2. Western Europe Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Saxenda Market

18.1. UK Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Saxenda Market

19.1. Germany Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Saxenda Market

20.1. France Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Saxenda Market

21.1. Eastern Europe Saxenda Market Overview

21.2. Eastern Europe Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Saxenda Market

22.1. North America Saxenda Market Overview

22.2. North America Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Saxenda Market

23.1. USA Saxenda Market Overview

23.2. USA Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Saxenda Market

24.1. Canada Saxenda Market Overview

24.2. Canada Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Saxenda Market

25.1. South America Saxenda Market Overview

25.2. South America Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Saxenda Market

26.1. Middle East Saxenda Market Overview

26.2. Middle East Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Saxenda Market

27.1. Africa Saxenda Market Overview

27.2. Africa Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Saxenda Market Competitive Landscape And Company Profiles

28.1. Saxenda Market Competitive Landscape

28.2. Saxenda Market Company Profiles

28.2.1. Novo Nordisk Overview, Products and Services, Strategy and Financial Analysis

28.2.2. 0 Overview, Products and Services, Strategy and Financial Analysis

28.2.3. 0 Overview, Products and Services, Strategy and Financial Analysis

28.2.4. 0 Overview, Products and Services, Strategy and Financial Analysis

28.2.5. 0 Overview, Products and Services, Strategy and Financial Analysis

29. Global Saxenda Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Saxenda Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Saxenda Market

32. Recent Developments In The Saxenda Market

33. Saxenda Market High Potential Countries, Segments and Strategies

33.1 Saxenda Market In 2029 - Countries Offering Most New Opportunities

33.2 Saxenda Market In 2029 - Segments Offering Most New Opportunities

33.3 Saxenda Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Saxenda Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Saxenda Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Global Saxenda Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: Asia-Pacific, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: China, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: India, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Japan, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: Australia, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: South Korea, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: Western Europe, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: UK, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: Germany, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: France, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: Eastern Europe, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: North America, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: USA, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: Canada, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: South America, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Middle East, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Africa, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 60: Novo Nordisk Financial Performance

Table 61: 0 Financial Performance

Table 62: 0 Financial Performance

Table 63: 0 Financial Performance

Table 64: 0 Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Saxenda Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Saxenda Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Global Saxenda Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: Asia-Pacific, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: China, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: India, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Japan, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: Australia, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: South Korea, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: Western Europe, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: UK, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: Germany, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: France, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: Eastern Europe, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: North America, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: USA, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: Canada, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: South America, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Middle East, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Africa, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 60: Novo Nordisk Financial Performance

Figure 61: 0 Financial Performance

Figure 62: 0 Financial Performance

Figure 63: 0 Financial Performance

Figure 64: 0 Financial Performance

Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

$8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Weight Loss Supplements Global Market Report 2025 – By Type (Liquid, Powder, Softgels, Pills, Other Types), By Ingredients (Vitamins & Minerals, Amino Acids, Natural Extracts/Botanicals), By Distribution (Offline Channel...

Weight Loss and Diet Management Global Market Report 2025 – By Diet( Better-For-You-Food and Beverages, Weight Loss Supplements, Meal Replacements, Low-Calorie Sweeteners, Other Diets), By Equipment( Fitness Equipment, S...

Weight Loss Products And Services Global Market Report 2025 – By Products( Food, Beverage, Supplements, Other Weight Loss Products ), By Services( Fitness Centers, Slimming Centers, Consultation Services, Other Services,...

Weight Loss Services Global Market Report 2025 – By Service( Slimming Centers, Fitness centers, Consulting services, Weight loss programs), By Equipment( Fitness equipment, Surgical equipment), By Diet( Meal, Beverages),...

Weight Loss Drugs Global Market Report 2025 – By Type (Liquid, Tablets, Capsules), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (Weight-Reducing Aid, Fat Absorption Inhibi...

Dietary Fibers Global Market Report 2025 – By Product( Soluble dietary fibers, Insoluble dietary fibers), By Raw Material( Fruits and Vegetables, Cereals and Grains, Legumes, Nuts and Seeds), By Application( Food and Bev...

Functional Food Market 2022 - By Product Type (Bakery & Cereals, Dairy Products, Meat, Fish & Eggs, Soy Products, Fats & Oils), By Application (Sports Nutrition, Weight Management, Immunity, Digestive Health, Clinical Nu...

Frequently Asked Questions

What is the definition of the Saxenda market?

How will the Saxenda market drivers and restraints affect the market dynamics? What forces will shape the Saxenda industry going forward?

The Saxenda market major growth driver - Rising Obesity Prevalence Drives Demand For Weight-Loss Treatments. For further insights on the Saxenda market, request a sample here

What is the forecast market size or the forecast market value of the Saxenda market?

The Saxenda market size has grown strongly in recent years. The saxenda market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increased prevalence of obesity, growth in sedentary lifestyles, rise in awareness of obesity-related health risks, increased adoption of weight management treatments, and expansion of healthcare access. The saxenda market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growing personalized medicine, expanding healthcare infrastructure, rising demand for non-surgical weight loss solutions, and increasing use of digital health tools. Major trends in the forecast period include the emergence of combination therapies for weight loss, increasing availability of prescription weight loss medications, rising adoption of digital health and fitness apps, integration of weight management solutions into primary care, and greater focus on sustainable lifestyle changes. For further insights on the Saxenda market, request a sample here

How is the Saxenda market segmented?

The saxenda market covered in this report is segmented –
1) By Indication: Obesity Management (Body Mass Index (BMI) of =30 kg/m²); Overweight Management (BMI of =27 kg/m² to <30 kg/m² with weight-related comorbidities)
2) By Dosage Form: Injection; Pre-filled pens
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
4) By End User: Hospitals And Clinics; Homecare Settings For further insights on the Saxenda market, request a sample here

Which region has the largest share of the Saxenda market? What are the other regions covered in the report?

Who are the major players in the Saxenda market?

Major companies operating in the saxenda market are Novo Nordisk . For further insights on the Saxenda market, request a sample here.

What are the key trends in the Saxenda market?

Major trends in the Saxenda market include Innovative Generic Products Expand Affordable Alternatives For Weight Management. For further insights on the Saxenda market, request a sample here.